Extension 1: First Temporary Rule
For Extension 1: First Temporary Rule, published is 05/10/2023; federal register citation is 88 FR 30037; document number is 2023-09936; effective period as stated is This rule is effective May 11, 2023, through November 11, 2024; flexibility extended through is November 11, 2023, verified against its source on 2026-08-31.
- Temporary rule
- Extension 1: First Temporary Rule our reading
- Published
- 05/10/2023 verified
- Federal Register citation
- 88 FR 30037 verified
- Document number
- 2023-09936 verified
- Effective period as stated
- This rule is effective May 11, 2023, through November 11, 2024. verified
- Flexibility extended through
- November 11, 2023 verified
- Longer extension for a narrower group
- through November 11, 2024, but only with respect to patients with whom the prescribing practitioner has a telemedicine relationship established via COVID-19 telemedicine prescribing flexibilities on or before November 11, 2023 verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
What the source says
A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 05/10/2023 Published Document: 2023-09936 (88 FR 30037)
— federalregister.gov, retrieved 2026-08-31
Where each value comes from
This source states these in separate places, so each value is shown with the passage that states it.
Effective period as stated
DATES: This rule is effective May 11, 2023, through November 11, 2024.
Flexibility extended through
Paragraph (c) extends the COVID-19 telemedicine prescribing flexibilities for six months, from May 12, 2023 through November 11, 2023, provided all of the conditions listed in paragraph (e) are met.
Longer extension for a narrower group
Paragraph (d) provides for a partial extension of those telehealth flexibilities through November 11, 2024, but only with respect to patients with whom the prescribing practitioner has a telemedicine relationship established via COVID-19 telemedicine prescribing flexibilities on or before November 11, 2023, as defined in paragraph (b) and provided all the conditions listed in paragraph (e) are met.
— all from federalregister.gov, retrieved 2026-08-31
Source
- federalregister.govhttps://www.federalregister.gov/documents/2023/05/10/2023-09936/temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled